Stem Cell Integral Membrane Transporter ABCB5 and Dermal Regeneration
Stem Cell Integral Membrane Transporter ABCB5 and Dermal Regeneration
批准号:
10707397
负责人:
Markus H. Frank
金额:
$53.9万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-05-31
关键词:
AddressAdultAgeAge YearsAgingAllogenicAnimal ModelAnti-Inflammatory AgentsAutologousBindingCell AgingCell CompartmentationCell Differentiation processCell MaintenanceCell SeparationCell TherapyCell membraneCell surfaceCellsChronicClinical TrialsDataDermalDermisDevelopmentDiseaseDocumentationElasticityEmploymentEndowmentEpidermisEpigenetic ProcessFamily memberFoundationsFrequenciesFunctional disorderGeneticGermanyHairHealthHomeostasisHumanImmuneImpaired wound healingImpairmentInflammagingInvestigationKnockout MiceMembrane ProteinsMembrane Transport ProteinsMesenchymal Stem Cell TransplantationMesenchymal Stem CellsModelingMolecularMusNatural regenerationOrganismPathway interactionsPatientsPharmaceutical PreparationsPreventionProspective StudiesReceptor Protein-Tyrosine KinasesRegenerative MedicineRegenerative capacityResearchRoleSignal PathwaySignal TransductionSkinSkin AgingSkin injurySomatic CellStem cell transplantTestingTherapeuticTissue DifferentiationVaricose UlcerVenous Insufficiencyadult stem cellage relatedangiogenesisappendagechronic woundexperimental studyimmunoregulationmouse modelnon-healing woundsnovelolder patientpre-clinicalrational designregenerativeregenerative tissuerepairedself-renewalskin disorderskin regenerationskin woundstem cell agingstem cell biologystem cell populationstem cellstongue papillatranslational impacttranslational potentialvasculogenesiswoundwound healing
中文摘要
项目摘要
项目3将测试以下中心假设:(1)ABCB 5(+)真皮间充质干细胞(DMSC)是
正常成人皮肤稳态和再生所需;(2)ABCB 5(+)DMSC下降负责
用于老化期间受损的皮肤稳态和再生伤口愈合;和(3)ABCB 5(+)DMSC
移植具有恢复与年龄相关的皮肤稳态损伤的治疗潜力,
再生这项研究的总体意义是研究范式的潜在转变,
从成功完成这项研究:(1)拟议的实验将回答一个基本的
干细胞生物学和衰老的问题,尚未解决的前瞻性研究-
成体干细胞区室中的选择性功能障碍(维斯于
分化组织)负责有机体老化?(2)记录再生
ABCB 5(+)DMSC的能力沿着其下降是年龄相关性损伤的原因
皮肤再生能力的提高将为有针对性地使用这种候选细胞奠定基础
用于治疗老年患者的皮肤伤口的治疗剂。
英文摘要
PROJECT SUMMARY
Project 3 will test the central hypotheses that (1) ABCB5(+) dermal mesenchymal stem cells (DMSC) are
required for normal adult skin homeostasis and regeneration; (2) ABCB5(+) DMSC decline is responsible
for impaired skin homeostasis and regenerative wound healing during aging; and (3) ABCB5(+) DMSC
transplantation possesses therapeutic potential to restore age-related impairment of skin homeostasis and
regeneration. The overall significance of this study are the potential shifts in research paradigms resulting
from successful completion of this research: (1) The proposed experiments will answer a fundamental
question in stem cell biology and aging that has not been addressed as-of-yet in prospective studies – To
what extent is selective dysfunction in an adult stem cell compartment (vis-à-vis dysregulation of
differentiated tissues) responsible for organismal aging?; and (2) Documentation of the regenerative
capacity of ABCB5(+) DMSC along with demonstration of their decline as a cause age-related impairment
of skin regenerative capacity will lay the foundation for targeted employment of this candidate cell
therapeutic for the treatment of cutaneous wounds in aging patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multicomponent Therapy for Age-related Skin Stem Cell Deficiency
-
批准号:10707346
-
项目类别:
-
资助金额:$223.18万
-
财政年份:2022
-
负责人:Markus H. Frank
-
依托单位:
Multicomponent Therapy for Age-related Skin Stem Cell Deficiency
-
批准号:10494654
-
项目类别:
-
资助金额:$235.16万
-
财政年份:2022
-
负责人:Markus H. Frank
-
依托单位:
Stem Cell Integral Membrane Transporter ABCB5 and Dermal Regeneration
-
批准号:10494660
-
项目类别:
-
资助金额:$58.0万
-
财政年份:2022
-
负责人:Markus H. Frank
-
依托单位:
Immunology of human malignant melanoma initiating cells
-
批准号:8532856
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2012
-
负责人:Markus H. Frank
-
依托单位:
Immunology of human malignant melanoma initiating cells
-
批准号:8239174
-
项目类别:
-
资助金额:$40.11万
-
财政年份:2012
-
负责人:Markus H. Frank
-
依托单位:
Immunology of human malignant melanoma initiating cells
-
批准号:8685190
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2012
-
负责人:Markus H. Frank
-
依托单位:
Immunology of human malignant melanoma initiating cells
-
批准号:9112874
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2012
-
负责人:Markus H. Frank
-
依托单位:
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
-
批准号:8307737
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2008
-
负责人:Markus H. Frank
-
依托单位:
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
-
批准号:8109826
-
项目类别:
-
资助金额:$33.76万
-
财政年份:2008
-
负责人:Markus H. Frank
-
依托单位:
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
-
批准号:7692241
-
项目类别:
-
资助金额:$32.76万
-
财政年份:2008
-
负责人:Markus H. Frank
-
依托单位:
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
-
批准号:7221226
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2006
-
负责人:Markus H. Frank
-
依托单位:
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
-
批准号:7034755
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2006
-
负责人:Markus H. Frank
-
依托单位:
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
-
批准号:7763930
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2006
-
负责人:Markus H. Frank
-
依托单位:
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
-
批准号:7576195
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2006
-
负责人:Markus H. Frank
-
依托单位:
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
-
批准号:7362437
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2006
-
负责人:Markus H. Frank
-
依托单位:
P-glycoprotein Function in Allograft Rejection
-
批准号:6422411
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2002
-
负责人:Markus H. Frank
-
依托单位:
P-glycoprotein Function in Allograft Rejection
-
批准号:6722805
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2002
-
负责人:Markus H. Frank
-
依托单位:
P-glycoprotein Function in Allograft Rejection
-
批准号:6620842
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2002
-
负责人:Markus H. Frank
-
依托单位:
海外基金